Zhongyan Technology (003001.SZ) signed new orders totaling 4.58 billion yuan in the fourth quarter of 2024.
Zhongyan Dadi (003001.SZ) disclosed its operating performance in the fourth quarter of 2024, with the company's new signed orders in the fourth quarter reaching...
Zhongyan Technology (003001.SZ) disclosed its operating performance for the fourth quarter of 2024. The company's new signed order amount for the fourth quarter was 458 million yuan, and the accumulated signed but unfinished order amount as of the end of the reporting period was 628 million yuan. The amount of bids won in the fourth quarter but not yet signed was 1.1944 million yuan.
Related Articles
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
